Phase I Study of Aprotinin in Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase I Combination w/ Epirubicin
- Status
- COMPLETED
- Phase
- PHASE1
Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
- Status
- COMPLETED
- Phase
- PHASE2
Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
- Status
- COMPLETED
- Phase
- PHASE2
Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
- Status
- UNKNOWN
- Phase
- PHASE3